R

Rocket Pharmaceuticals

D

RCKT

USD

0.56

(2.6897%)

Market Closed

16,208.00

حجم التداول

-2.466

الربح لكل سهم

-

العائد الربحي

-7.718412

P/E

1,945,063,865.42

حجم السوق

اليوم

2.6897%

1 اسبوع

12.823%

1 شهر

11.238%

6 اشهر

-20.372%

12 اشهر

-7.003%

بداية السنة

-28.519%

كل الوقت

0%

أصول ذات صلة

Title:
Rocket Pharmaceuticals

Sector:

Healthcare

Industry:

Biotechnology

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا